title: Recent progress in pancreatic cancer.
abstract: Pancreatic cancer is currently one of the deadliest of the solid malignancies. However, surgery to resect neoplasms of the pancreas is safer and less invasive than ever, novel drug combinations have been shown to improve survival, advances in radiation therapy have resulted in less toxicity, and enormous strides have been made in the understanding of the fundamental genetics of pancreatic cancer. These advances provide hope but they also increase the complexity of caring for patients. It is clear that multidisciplinary care that provides comprehensive and coordinated evaluation and treatment is the most effective way to manage patients with pancreatic cancer.
authors.affiliation: Associate Professor, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD; Associate Professor, Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD; Associate Professor, Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: Christopher L
authors.initials: CL
authors.lastname: Wolfgang
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Herman
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Laheru
authors.forename: Alison P
authors.initials: AP
authors.lastname: Klein
authors.forename: Michael A
authors.initials: MA
authors.lastname: Erdek
authors.forename: Elliot K
authors.initials: EK
authors.lastname: Fishman
authors.forename: Ralph H
authors.initials: RH
authors.lastname: Hruban
mesh_terms: D000230:Adenocarcinoma / Q000209:etiology / Q000628:therapy*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000209:etiology / Q000628:therapy*; D012307:Risk Factors
keywords: medical oncology; molecular biology; pancreatic neoplasms; radiation oncology; radiology